Ronald L. Gibson

14.0k citations

130 papers · 9.8k indexed · 4 hit papers · h-index 47

Pulmonary and Respiratory Medicine top 0.1%
Molecular Biology top 5%
Epidemiology top 1%
Molecular Medicine top 0.2%
Infectious Diseases top 1%

Co-authors: Bonnie W. Ramsey Jane L. Burns Julia Emerson Sharon McNamara Margaret Rosenfeld George Retsch‐Bogart Karen McCoy Christopher M. Oermann
Topics: Cystic Fibrosis Research Advances (95 papers)Neonatal Respiratory Health Research (35 papers)Tracheal and airway disorders (33 papers)
Cited by: Molecular Medicine Pulmonary and Respiratory Medicine Critical Care and Intensive Care Medicine
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Clinical Investigation
Partner nations: United States United Kingdom Canada

In The Last Decade

Ronald L. Gibson

124 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

2003 1.2k citations Ronald L. Gibson, Jane L. Burns et al. American Journal of Respiratory and Critical Care Medicine profile →
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis

2002 788 citations Julia Emerson, Margaret Rosenfeld et al. Pediatric Pulmonology profile →
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

2015 360 citations Ronald L. Gibson et al. profile →
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

2015 303 citations Ronald L. Gibson et al. profile →

Peers

Countries citing papers authored by Ronald L. Gibson

Since Specialization

Citations

This map shows the geographic impact of Ronald L. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald L. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald L. Gibson more than expected).

Fields of papers citing papers by Ronald L. Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald L. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald L. Gibson. The network helps show where Ronald L. Gibson may publish in the future.

Co-authorship network of co-authors of Ronald L. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald L. Gibson. A scholar is included among the top collaborators of Ronald L. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald L. Gibson. Ronald L. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice 2025 ·eLife ·Malika Hale,Kennidy K. Takehara,Christopher D. Thouvenel,Dina A. Moustafa,(unknown),Mary F. Fontana,Jason Netland,Sharon McNamara,Ronald L. Gibson,Joanna B. Goldberg,David J. Rawlings,Marion Pepper	0
2	Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice 2024 ·eLife ·Malika Hale,Kennidy K. Takehara,Christopher D. Thouvenel,Dina A. Moustafa,(unknown),Mary F. Fontana,Jason Netland,Sharon McNamara,Ronald L. Gibson,Joanna B. Goldberg,David J. Rawlings,Marion Pepper	0
3	Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis 2024 ·Hepatology ·Jaclyn R. Stonebraker,Rhonda G. Pace,Paul J. Gallins,Hong Dang,Melis A. Aksit,Anna Faino,(unknown),Sonya A. MacParland,Michael J. Bamshad,Ronald L. Gibson,Garry R. Cutting,Peter R. Durie,Fred A. Wright,Yi‐Hui Zhou,Scott M. Blackman,Wanda K. O’Neal,Simon C. Ling,Michael R. Knowles	2
4	Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations 2023 ·Journal of Cystic Fibrosis ·Anna Faino,Lucas R. Hoffman,Ronald L. Gibson,Matthew P. Kronman,David P. Nichols,Margaret Rosenfeld,Jonathan D. Cogen	5
5	Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis 2023 ·Journal of Cystic Fibrosis ·Margaret Rosenfeld,Anna Faino,Pingping Qu,Frankline Onchiri,Elizabeth Blue,Joseph M. Collaco,(unknown),Rhonda D. Szczesniak,Yi‐Hui Zhou,Michael J. Bamshad,Ronald L. Gibson	6
6	Club cell secretory protein and lung function in children with cystic fibrosis 2022 ·Journal of Cystic Fibrosis ·Jing Zhai,Mary J. Emond,Amber Spangenberg,Debra A. Stern,Monica M. Vasquez,Elizabeth Blue,Kati J. Buckingham,Duane L. Sherrill,Marilyn Halonen,Ronald L. Gibson,Margaret Rosenfeld,Scott D. Sagel,Michael J. Bamshad,Wayne J. Morgan,Stefano Guerra	11
7	Comparing encounter-based and annualized chronic pseudomonas infection definitions in cystic fibrosis 2021 ·Journal of Cystic Fibrosis ·Margaret Rosenfeld,Anna Faino,Frankline Onchiri,Melis A. Aksit,Scott M. Blackman,Elizabeth Blue,Joseph M. Collaco,(unknown),Rhonda G. Pace,Karen S. Raraigh,Yi‐Hui Zhou,Garry R. Cutting,Michael R. Knowles,Michael J. Bamshad,Ronald L. Gibson	6
8	Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results 2017 ·American Journal of Respiratory and Critical Care Medicine ·Noah Lechtzin,Nicole Mayer-Hamblett,Natalie E. West,Sarah Allgood,(unknown),Umer Khan,Moira L. Aitken,Bonnie W. Ramsey,Michael Boyle,Peter J. Mogayzel,Ronald L. Gibson,David M. Orenstein,Carlos Milla,John Clancy,Veena B. Antony,Christopher H. Goss	86
9	Pseudomonas aeruginosa In Vitro Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes 2014 ·American Journal of Respiratory and Critical Care Medicine ·Nicole Mayer-Hamblett,Margaret Rosenfeld,Ronald L. Gibson,Bonnie W. Ramsey,Hemantha D. Kulasekara,George Retsch‐Bogart,Wayne J. Morgan,Daniel J. Wolter,Christopher E. Pope,Laura S. Houston,Bridget R. Kulasekara,Umer Khan,Jane L. Burns,Samuel I. Miller,Lucas R. Hoffman	79
10	Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort 2012 ·Journal of Cystic Fibrosis ·Margaret Rosenfeld,Julia Emerson,Sharon McNamara,Valeria Thompson,Bonnie W. Ramsey,Wayne J. Morgan,Ronald L. Gibson	67
11	Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state 2012 ·Journal of Cystic Fibrosis ·Bradley S. Quon,Donald L. Patrick,Todd C. Edwards,Moira L. Aitken,Ronald L. Gibson,Alan Genatossio,Sharon McNamara,Christopher H. Goss	12
12	Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings 2011 ·Influenza and Other Respiratory Viruses ·Jane L. Burns,Julia Emerson,Jane Kuypers,Angela P. Campbell,Ronald L. Gibson,Sharon McNamara,(unknown),Janet A. Englund	42
13	Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis 2011 ·Pediatric Pulmonology ·Nicole Mayer‐Hamblett,Richard A. Kronmal,Ronald L. Gibson,Margaret Rosenfeld,George Retsch‐Bogart,Miriam M. Treggiari,Jane L. Burns,Umer Khan,Bonnie W. Ramsey,(unknown)	69
14	Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis 2008 ·American Journal of Respiratory and Critical Care Medicine ·Karen McCoy,Alexandra L. Quittner,Christopher M. Oermann,Ronald L. Gibson,George Retsch‐Bogart,A. Bruce Montgomery	269
15	Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection 2005 ·Journal of Antimicrobial Chemotherapy ·Samuel M. Moskowitz,(unknown),Julia Emerson,Ronald L. Gibson,Jane L. Burns	37
16	Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis 2003 ·American Journal of Respiratory and Critical Care Medicine ·Claudia L. Ordoñez,Noreen Henig,Nicole Mayer-Hamblett,Frank J. Accurso,Jane L. Burns,James F. Chmiel,Cori Daines,Ronald L. Gibson,Sharon McNamara,George Retsch‐Bogart,Pamela L. Zeitlin,Moira L. Aitken	144
17	Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosisbreakdown → 2003 ·American Journal of Respiratory and Critical Care Medicine ·Ronald L. Gibson,Jane L. Burns,Bonnie W. Ramsey	1239
18	Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis 2003 ·American Journal of Respiratory and Critical Care Medicine ·Ronald L. Gibson,Julia Emerson,Sharon McNamara,Jane L. Burns,Margaret Rosenfeld,(unknown),N. Hamblett,Frank J. Accurso,Mark Dovey,Peter Hiatt,Michael W. Konstan,Richard B. Moss,George Retsch‐Bogart,Jeffrey S. Wagener,David Waltz,Robert W. Wilmott,Pamela L. Zeitlin,Bonnie W. Ramsey	243
19	Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis* 2001 ·Pediatric Pulmonology ·Margaret Rosenfeld,Ronald L. Gibson,Sharon McNamara,Julia Emerson,Jane L. Burns,Robert G. Castile,Peter Hiatt,Karen McCoy,Christopher Wilson,Andrew Inglis,Arnold L. Smith,Thomas R. Martin,Bonnie W. Ramsey	304
20	Home Care of Terminal Malignant Disease 1971 ·Journal of the Royal College of Physicians of London ·Ronald L. Gibson	1

About Ronald L. Gibson

Ronald L. Gibson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine and Epidemiology, having authored 130 papers that have together received 9.8k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (95 papers), Neonatal Respiratory Health Research (35 papers) and Tracheal and airway disorders (33 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Pulmonary and Respiratory Medicine (6.9k citations) and Critical Care and Intensive Care Medicine (480 citations). Ronald L. Gibson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Bonnie W. Ramsey, Jane L. Burns, Julia Emerson, Sharon McNamara, Margaret Rosenfeld, George Retsch‐Bogart, Karen McCoy, Christopher M. Oermann, Arnold L. Smith and A. Bruce Montgomery. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact